High levels of KIAA1522 expression could contribute to tumorigenesis, be linked to innate immunity, such as immune cell infiltration and humoral immunity, and have an impact on HCC by inhibiting tumor suppressor-related pathways like fatty acid metabolism and liver protective mechanisms like the PPAR signaling pathway. The gene discussed is NHSL3; the disease is hepatocellular carcinoma.